Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for Hepatitis B Virus (HBV) infection screening, effective May 15, 2026. Here's what billing teams need to do.
CMS Hepatitis B Virus screening coverage policy changes affect preventive services billing across primary care, internal medicine, OB/GYN, and infectious disease practices. This specific policy document does not list applicable CPT or HCPCS codes — we'll address what that means for your claim submissions below. If your team handles Medicare preventive screenings, read this before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Screening for Hepatitis B Virus (HBV) Infection |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | 2026-05-15 |
| Impact Level | High |
| Specialties Affected | Primary care, internal medicine, OB/GYN, infectious disease, federally qualified health centers |
| Key Action | Audit your HBV screening charge capture and documentation against updated CMS medical necessity criteria before May 15, 2026 |
CMS Hepatitis B Virus Screening Coverage Criteria and Medical Necessity Requirements 2026
CMS covers HBV screening as a preventive benefit under Medicare Part B. The core medical necessity framework has existed since CMS finalized coverage for hepatitis B screening — but modifications to this policy signal a meaningful shift in how the agency defines who qualifies, under what conditions, and how often.
The Centers for Medicare & Medicaid Services bases HBV screening coverage on population-level risk criteria. Historically, CMS has covered screening for adults at increased risk for HBV infection, including persons born in regions with HBV prevalence of 2% or higher, U.S.-born persons not vaccinated as infants whose parents were born in regions with HBV prevalence of 8% or higher, HIV-positive individuals, and injection drug users. The modification to this policy may adjust, expand, or clarify these criteria — and your billing team needs to document exactly which criterion applies to each patient before submitting a claim.
This is not a coverage policy where you can rely on "preventive screening" as a catch-all justification. CMS requires documented medical necessity tied to specific risk factors. A claim denial on HBV screening often traces back to missing or vague documentation of why the patient qualifies — not a billing error in the traditional sense.
Whether prior authorization is required for HBV screening under Medicare is straightforward: Medicare Part B preventive services typically don't require prior authorization when billed correctly as preventive. But that only holds when you bill the right code with the right diagnosis and hit the correct frequency limits. Stray from those parameters, and you're looking at a medical necessity denial or a frequency edit rejection.
Reimbursement for HBV screening under Medicare is tied to the Medicare Physician Fee Schedule. Rates vary by locality, but the bigger financial exposure here is not the rate — it's volume. If your practice screens hundreds of patients annually and the 2026 policy modification narrows or clarifies the covered population, even a small shift in covered indications can translate to significant claim denial exposure.
CMS Hepatitis B Virus Screening Exclusions and Non-Covered Indications
CMS does not cover HBV screening as a routine annual benefit for the general Medicare population. Coverage is not triggered by a patient simply requesting screening. The patient must meet documented risk criteria.
Screening ordered purely as part of a general wellness visit without documented HBV risk factors is not covered as a standalone preventive screening claim. If your providers are ordering HBV panels broadly without tying orders to specific risk criteria, that's a compliance problem — not just a billing problem.
Confirmatory or diagnostic testing following a positive screen is a separate clinical and billing event. That testing falls outside the screening coverage policy and gets billed under diagnostic coding rules. Your team needs to distinguish clearly between the screening encounter and any follow-up diagnostic work that flows from it.
Coverage Indications at a Glance
This policy document does not provide indication-level code data. The table below reflects established CMS HBV screening coverage criteria based on the published Medicare preventive services framework. Confirm these against the updated policy at the effective date of May 15, 2026.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Adults at high risk — born in HBV-endemic region (≥2% prevalence) | Covered | Not listed in policy | Document country of origin and prevalence data in chart |
| Adults at high risk — injection drug use, current or past | Covered | Not listed in policy | Document risk factor explicitly in visit note |
| HIV-positive adults | Covered | Not listed in policy | HIV diagnosis should appear on claim |
| Adults with multiple sex partners or history of STI | Covered | Not listed in policy | Risk factor documentation required |
| Routine annual screening, general population (no risk factors) | Not Covered | Not listed in policy | Will deny as not medically necessary |
| Diagnostic follow-up testing post-positive screen | Not Covered under screening benefit | Not listed in policy | Bill under diagnostic codes, not preventive |
| Pregnant women (per USPSTF recommendations) | Covered | Not listed in policy | Confirm frequency and trimester documentation |
CMS Hepatitis B Virus Screening Billing Guidelines and Action Items 2026
The effective date is May 15, 2026. That gives your team a window to act. Here's what to do before that date.
| # | Action Item |
|---|---|
| 1 | Pull your HBV screening claims from the last 12 months and audit them. Look specifically at the diagnosis codes attached to each claim. If you see screenings billed without a documented risk-factor diagnosis, those claims were already at denial risk — and the 2026 modification may increase scrutiny. |
| 2 | Confirm which CPT and HCPCS codes your MAC accepts for HBV screening. This policy document does not list specific codes. Contact your Medicare Administrative Contractor directly or check your MAC's local coverage determination (LCD) for HBV screening. Your MAC's LCD is the governing document for code-level billing guidance in your region. |
| 3 | Update your order sets and intake workflows to capture HBV risk factors before the encounter closes. The chart needs to show why the patient qualifies — country of birth, risk behaviors, HIV status, or other documented indicators. A screening code without that documentation will not hold up on audit. |
| 4 | Check your frequency edits. Medicare limits HBV screening to specific intervals. If your practice management system doesn't flag frequency conflicts at charge entry, you're submitting preventable denials. Fix that logic before May 15, 2026. |
| 5 | Separate your screening billing from your diagnostic billing in your EHR workflows. Providers who document the screening encounter and the follow-up interpretation in the same note often cause coders to blur the line between a covered screen and non-covered diagnostic service. That bundling creates claim denial risk. Add clear documentation prompts so coders know where the screening ends and diagnostic workup begins. |
| 6 | Talk to your compliance officer before the effective date if your practice bills HBV screening at high volume. The modification to this coverage policy is real, and the published policy document doesn't include codes — which is an unusual gap. That ambiguity is worth a direct compliance review, not a guess. |
If your billing team handles federally qualified health centers, rural health clinics, or patients covered under both Medicare and Medicaid (dual eligibles), HBV screening billing guidelines get more complex. Medicaid coverage rules vary by state. Don't assume Medicare rules map directly to your Medicaid population.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for HBV Screening Under This Policy
This policy document does not list specific CPT, HCPCS, or ICD-10 codes. That is not a formatting omission — the source policy data contains no code information. This is an important operational fact for your billing team.
What This Means for Your Charge Capture
Without code-level guidance in the policy itself, you have two authoritative sources to check. First, contact your Medicare Administrative Contractor and request their current LCD or article on Hepatitis B Virus screening. Second, reference the Medicare Preventive Services Chart from CMS.gov, which maps preventive benefits to HCPCS codes and frequency limits.
Common codes associated with HBV screening under Medicare include HCPCS G-codes for preventive services and CPT codes for hepatitis B surface antigen testing — but because this policy does not list them, we will not publish specific codes here as authoritative. Publishing codes not confirmed in the policy source creates a real-world claim denial risk if your team acts on incorrect information.
Your Action on Codes
Call your MAC's provider outreach line. Ask specifically: "What CPT or HCPCS codes apply to HBV screening under Medicare, and has CMS issued updated billing guidelines effective May 15, 2026?" Get the answer in writing. Then update your charge capture accordingly.
This is one of those situations where the gap in the policy document is itself the signal. When CMS modifies a policy without publishing updated code-level guidance simultaneously, that often means a follow-up transmittal or contractor article is coming. Set a watch on your MAC's website and on PayerPolicy for updates between now and May 15, 2026.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.